pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Ermeza
drug
save

Ermeza

Marketedupdated 3mo ago
by $VTRS Viatris Inc
Approved
community read0 votes

🐶 often sniffed alongside

top 8
  • druglevothyroxine sodium42 co-mentions · 37 sources
  • drugLevoxyl41 co-mentions · 37 sources
  • drugEuthyrox40 co-mentions · 37 sources
  • drugTirosint40 co-mentions · 37 sources
  • drugLevolet40 co-mentions · 37 sources
  • tagRecall38 co-mentions · 37 sources
  • companyAccord Healthcare Inc28 co-mentions · 13 sources
  • companyMylan Pharmaceuticals Inc19 co-mentions · 19 sources

all catalysts(0)

nothing on the calendar yet

Trials studying Ermeza

  • phase4Use of Tirosint®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH)terminatedn=34
  • phase2Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidismcompletedn=46
  • phase1Fasting Study of Levothyroxine Sodium Tablets 300 mcg to Synthroid® Tablets 300 mcgcompletedn=33
  • phase1Fasting Study of Levothyroxine Sodium Tablets 300 μg to Levothroid® Tablets 300 μgcompletedn=32
  • phase1Fasting Study of Levothyroxine Sodium Tablets 300 μg to Synthroid® Tablets 300 μgcompletedn=30
  • phase1Fasting Study of Levothyroxine Sodium Tablets 200 mg to Synthroid Tablets 200 mgcompletedn=32

News(0)

no news has mentioned this drug yet

brand
Ermeza
generic
levothyroxine sodium
indication
Hypothyroidism
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 9m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?